- Home
- About Us
- CE Opportunities
- Faculty
- Reviews
- Sponsors
- News
- Library
- Articles
- Hyperosmolarity: Effects on the Ocular Surface
- Inflammation: Role in Dry Eye Disease
- Early Intervention: Dry Eye Disease
- Effective Dietary Supplements For Dry Eye Symptoms
- New Treatment for Meibomian Gland Dysfunction
- Hyperosmolarity II: Diagnosis and Treatment of Dry Eye Disease
- Inflammation II: Treatment in Dry Eye Disease
- Meibomian Glands II: Assessment and Treatment
- Ocular Surface Mucins: Role in Dry Eye Disease
- Two Perspectives on Perimenopause and Dry Eye
- Treating the Inflammatory Component of Dry Eye Disease
- What Is New and Effective for Treating Ocular Allergies
- Meibomian Glands I: Role in Dry Eye Disease
- The Origins of Ocular Allergy
- Pearls: Management of Recurrent Corneal Erosion
- Meibomian Glands II
- The Effect of Cyclosporine on LASIK Outcomes
- Pearls: Blepharitis Treatment Protocol
- Long-term Management of Dry Eye Disease
- Taking a Fresh Look at Lid Margin Disease
- Risk Factors for Microbial Keratitis in Contact Lens Wearers
- Visual Performance in Dry Eye Patients
- Dry Eye and Blepharitis: Dealing with the Chronic Ocular Irritation Patient
- Contact Lens-Induced Dry Eye
- Motivating Dispensary Staff
- Diagnosis and Treatment of Conjunctival Chalasis
- Contact Lens Rewetting Drops
- Today’s Refractive Surgery Patient
- Sjogrens Syndrome
- Optimizing the Treatment of Ocular Allergy
- Steroids in the Treatment of Blepharitis
- Our EHR Journey: The Early Stages
- Steroids in the Treatment of Dry Eye Disease
- Drugs and Laser Treatments for Diabetic Retinopathy
- Our EHR Journey: Where We Are Now
- The Importance of Staging Dry Eye Disease
- Hyaluronic Acid for the Ocular Surface
- Ganciclovir Gel: An Important New Treatment Option for Herpes Keratitis
- Forms
- Policies
- Articles
- Rewards
- Members
Optimizing the Treatment of Ocular Allergy


While patients use the term “allergy” quite broadly, not all adverse reactions to food, pet hair, or pollen are the result of a true allergic response. Strictly defined, allergy is a dynamic, active immune defense against a protein, typically associated with the allergic antibody immunoglobulin E (IgE). While other hypersensitivities may produce similar symptoms, they often result from a chemical reaction or other non-immune mechanism.
Because histamine release is central to the allergic response, topical antihistamines are usually a very effective treatment for allergic conjunctivitis. With drugs such as Patanol® (Alcon), Pataday™ (Alcon), Elestat® (Allergan), and Bepreve™ (ISTA Pharmaceuticals), clinicians currently have a number of options from which to choose. When selecting one of these medications, clinicians should consider the comfort of the drop and the dosing frequency, as both factors can significantly affect patient compliance. If cost is an issue, ketotifen is now available in over-the-counter formulations, including Alaway® (Bausch & Lomb) and Zaditor® (Novartis).